EMA Authorised: Levetiracetam Teva (levetiracetam) — Teva B.V.

View source ↗

Summary

EMA has authorised Levetiracetam Teva (levetiracetam) for the treatment of epilepsy. The marketing authorization holder is Teva B.V., with decision date 22 Janu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Levetiracetam Teva (levetiracetam)

Snippet

Status: Authorised. Therapeutic area: Epilepsy. MAH: Teva B.V.. Decision date: 22/01/2026